Literature DB >> 23287626

CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL.

Mascha Binder, Fabian Müller, Mareike Frick, Claudia Wehr, Frédéric Simon, Bernd Leistler, Hendrik Veelken, Roland Mertelsmann, Martin Trepel.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23287626     DOI： 10.1182/blood-2012-09-454439

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

Review 1.  B cell receptor signaling in chronic lymphocytic leukemia.

Authors:  Jan A Burger; Nicholas Chiorazzi
Journal:  Trends Immunol       Date:  2013-08-05       Impact factor: 16.687

Review 2.  Targeting the B cell receptor pathway in non-Hodgkin lymphoma.

Authors:  Kelly Valla; Christopher R Flowers; Jean L Koff
Journal:  Expert Opin Investig Drugs       Date:  2018-06-07       Impact factor: 6.206

Review 3.  Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Authors:  Elisa Ten Hacken; Jan A Burger
Journal:  Biochim Biophys Acta       Date:  2015-07-17

4.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

Review 5.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

6.  Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.

Authors:  Yun Liu; Chelsea D Higgins; Cathie M Overstreet; Kanti R Rai; Nicholas Chiorazzi; Jonathan R Lai
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

7.  Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia.

Authors:  A F Muggen; S Y Pillai; L P Kil; M C van Zelm; J J M van Dongen; R W Hendriks; A W Langerak
Journal:  Leukemia       Date:  2014-06-11       Impact factor: 11.528

Review 8.  Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors:  Jan A Burger; Adrian Wiestner
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

9.  Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.

Authors:  Stefano Iacovelli; Eva Hug; Sara Bennardo; Marcus Duehren-von Minden; Stefania Gobessi; Andrea Rinaldi; Mirza Suljagic; Daniel Bilbao; Giulia Bolasco; Julia Eckl-Dorna; Verena Niederberger; Francesco Autore; Simona Sica; Luca Laurenti; Hongsheng Wang; Richard J Cornall; Stephen H Clarke; Carlo M Croce; Francesco Bertoni; Hassan Jumaa; Dimitar G Efremov
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

10.  Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations.

Authors:  Domenico Maisano; Enrico Iaccino; Alessandro D'Ambrosio; Federico Chiurazzi; Vincenzo Dattilo; Mariangela Scalise; Massimo Gentile; Eleonora Vecchio; Nancy Nisticò; Annamaria Aloisio; Erika De Sensi; Giuseppe Fiume; Ileana Quinto; Selena Mimmi
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.